Back

Understanding the risk of hyperkalaemia in heart failure.

1 September 2020 (18:45 - 19:00)
Organised by:
Congress Presentation Part of: Changing the outlook for a chronic heart failure patient: Optimising RAASi treatment through long-term potassium control Clinical Open Access ESC Congress 2020

About the speaker

Photo
Professor Piotr Ponikowski

Wroclaw Medical University, Wroclaw (Poland)

4 More presentations in this session

Presentation thumbnail
Introduction.
Professor P. Van Der Meer (Groningen, NL)
Video
Presentation thumbnail
Heart Failure, a multimorbid syndrome: The increasing challenge to manage.
Professor C. Lam (Singapore, SG)
Video
Presentation thumbnail
How may novel potassium binders help improve the management of chronic heart failure?
Professor J. Butler (Dallas, US)
Video
Presentation thumbnail
Discussion.
Professor P. Ponikowski (Wroclaw, PL) Professor P. Van Der Meer (Groningen, NL) Professor C. Lam (Singapore, SG) Professor J. Butler (Dallas, US)
Video

Access the full session

Session thumbnail
Changing the outlook for a chronic heart failure patient: Optimising RAASi treatment through long-term potassium control
Video

The Event

Event poster

ESC Congress 2020

1 September 2020 18:45 CET
You may be interested in
thumbnail
Webinar
How to optimise RAASi therapy in patients with hyperkalaemia
15 December 2021
thumbnail
Webinar
Current pacing perspectives for patients with heart failure
6 March 2024
thumbnail
Congress Session
Solving the puzzle of heart failure treatment
18 May 2025
thumbnail
Congress Presentation
Dapagliflozin reduces the risk of hyperkalaemia in patients with heart failure and reduced ejection fraction: a secondary analysis DAPA-HF
29 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources